SEC Form 4 · accession 0001209191-17-039337
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred M Powell
Officer — Senior Vice President & CFO
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 8:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 9, 2017 | P | 130,000 | $2.7944 | A | 331,434 | D |
Table II — derivative securities
No Table II lines on this filing.